Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  


Cleveland StrokeNet

The Cleveland StrokeNet is offering a Clinical Research and Training Award focused on training in research methodologies and conduct of research related to cerebrovascular diseases. The Cleveland StrokeNet is a collaboration of clinical cerebrovascular programs at University Hospitals of Cleveland, Cleveland Clinic, MetroHealth Medical Center, and Louis Stokes Cleveland VA Medical Center and is funded by the National Institutes of Neurological Disorders and Stroke (NINDS).

This Clinical Research and Training Award is open to clinical and/or research fellows, postdoctoral fellows and faculty within 5 years of training who wish to devote a significant portion of their career to methodologically rigorous research. It is designed to provide research support to allow the investigator to obtain external grant funding in an area of cerebrovascular research, which could include (but are not limited to) primary prevention, acute management, mechanisms of ischemia, genetics, rehabilitation and recovery, and secondary prevention.

The investigator must spend 50% of their effort on research during the period of the award. Applications are due February 1, 2015.

Application instructions:
Send the attached completed application and (2) current CV to Irene Katzan MD at katzani@ccf.org.

 
NEW Limited Submission: American Diabetes Association Pathway to Stop Diabetes

Key Deadlines: March 2, 2015, 5:00pm (CWRU Internal Submission Deadline), July 1, 2015, 8:00pm EST.

To accelerate the research needed to discover solutions and ultimately cure this deadly epidemic, the American Diabetes Association has launched a bold initiative, Pathway to Stop Diabetes, to inspire a new generation of diabetes researchers. Pathway will provide crucial support to individuals focusing on innovative ideas and transformational approaches that will lead to ground-breaking discoveries in diabetes prevention, treatment and cures.

Pathway will support creative scientists early in their diabetes research careers, or investigators who are established in other disciplines but would like to expand their focus to diabetes research. Through awards of $1.625 million over the course of up to seven years, the program will provide researchers the freedom, autonomy, time and focus needed to explore new ideas.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
New Biographical Sketch Format Required for Grant Applications

The National Institutes of Health (NIH) has announced that a new biographical sketch format is to be used in all grant applications with due dates on or after January 25th, 2015.

See the NIH Guide notice for more details: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-024.html

 

Case Comprehensive Cancer Center

All Faculty members are invited to submit concept proposals for 5 year Projects to compete for incorporation as a full project proposal in the upcoming GI SPORE competing renewal application that will be prepared starting in January 2015 for submission in September 2015 All proposals must be directed towards translational research of a GI malignancy, with at least one specific aim that involves direct study of patients or of human tissues.

Proposals must include two project leaders; one Basic Science leader and one Clinical leader. Maximum Funding Level – $185,000/year direct cost for 5 years ($925,000 total direct costs).

Completed proposals must be emailed to John Pounardjian, hxp125@case.edu. For more information on GI SPORE, visit the CaseCCC website.

 
amfAR, The Foundation for AIDS Research

amfAR, The Foundation for AIDS Research, has announced the availability of funding to support research relevant to exploring HIV persistence and the potential for HIV eradication. amfAR has established a new funding mechanism known as Impact Grants to support the in-depth development of concepts where preliminary data have indicated genuine promise in curing HIV. Impact Grants are conducted over a four-year funding period with up to $2,000,000 in total funding (including up to 20% indirect costs) and should include basic, animal and clinical (in vivo or ex vivo) research. Impact Grants aim to directly inform clinical efforts to safely eliminate or control latent/persistent HIV reservoirs. Priority will be given to projects with a clear pathway to development of an implementable intervention in humans.

Total Cost Maximum: $2,000,000

Performance Period: 4 years (July 1, 2015 – June 30, 2019)

Portal Request Form Deadline: Friday, February 27, 2015, 3:00 PM ET
Letter of Intent Submission Deadline: Tuesday, March 3, 2015, 3:00 PM ET
Hardcopy of Signed Face Page By Mail: Tuesday, March 24, 2015

For more information and to review the complete RFP visit the amfAR website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.